全文获取类型
收费全文 | 332篇 |
免费 | 27篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 13篇 |
妇产科学 | 1篇 |
基础医学 | 59篇 |
口腔科学 | 4篇 |
临床医学 | 9篇 |
内科学 | 119篇 |
皮肤病学 | 1篇 |
神经病学 | 14篇 |
特种医学 | 7篇 |
外科学 | 64篇 |
综合类 | 1篇 |
预防医学 | 9篇 |
药学 | 25篇 |
肿瘤学 | 5篇 |
出版年
2023年 | 2篇 |
2021年 | 2篇 |
2020年 | 2篇 |
2018年 | 3篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 5篇 |
2012年 | 8篇 |
2011年 | 20篇 |
2010年 | 8篇 |
2009年 | 8篇 |
2008年 | 13篇 |
2007年 | 18篇 |
2006年 | 18篇 |
2005年 | 17篇 |
2004年 | 14篇 |
2003年 | 8篇 |
2002年 | 5篇 |
2001年 | 14篇 |
2000年 | 5篇 |
1999年 | 10篇 |
1998年 | 4篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 5篇 |
1992年 | 16篇 |
1991年 | 12篇 |
1990年 | 9篇 |
1989年 | 10篇 |
1988年 | 10篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 9篇 |
1983年 | 9篇 |
1982年 | 6篇 |
1981年 | 2篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 3篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1970年 | 2篇 |
1969年 | 1篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有359条查询结果,搜索用时 15 毫秒
351.
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia 总被引:3,自引:0,他引:3
Guillet B Kriaa F Huysse MG Proulle V George C Tchernia G D'Oiron R Laurian Y Charpentier B Lambert T Dreyfus M 《British journal of haematology》2001,114(4):837-844
Acquired haemophilia is a life-threatening disorder caused by circulating auto-antibodies that inhibit factor VIII coagulant activity (FBIII:C). Immunoadsorption on protein A sepharose (IA-PA) was performed in two bleeding patients with acquired haemophilia: we observed a dramatic and quick decrease in the anti-FVIII:C inhibitor titre leading to a normal, albeit transient, haemostatic status. In one case, IA-PA was the only procedure which succeeded in stopping massive haemorrhage. In the second case, IA-PA reinforced the haemostatic effect of recombinant activated factor VII by increasing the endogenous plasma factor VIII level. The efficacy of IA-PA was sustained with immunosuppressive treatment introduced, respectively, 10 and 15 d before the IA-PA procedures. Our experience with IA-PA suggests that this extracorporeal anti-FVIII:C removal procedure is a valuable therapeutic tool for acquired haemophilia and can alleviate life-threatening haemorrhages. 相似文献
352.
353.
Jürgen Glas Astrid Konrad Silke Schmechel Julia Dambacher Julia Seiderer Frieder Schroff Martin Wetzke Darina Roeske Helga-Paula T?r?k Laurian Tonenchi Simone Pfennig Dirk Haller Thomas Griga Wolfram Klein J?rg T Epplen Christian Folwaczny Peter Lohse Burkhard G?ke Thomas Ochsenkühn Thomas Mussack Matthias Folwaczny Bertram Müller-Myhsok Stephan Brand 《The American journal of gastroenterology》2008,103(3):682-691
354.
Vlase L Popa A Neag M Muntean D Bâldea I Leucuţa SE 《Journal of clinical pharmacology》2011,51(8):1233-1236
The objective of this study was to evaluate the pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers. The study consisted of 2 periods: period 1 (reference), when each volunteer received a single dose of 5 mg zolpidem, and period 2 (test), when each volunteer received a single dose of 5 mg zolpidem and 400 mg carbamazepine. Between the 2 periods, the participants were treated for 15 days with a single daily dose of 400 mg carbamazepine. Pharmacokinetic parameters of zolpidem administered in each treatment period were calculated using noncompartmental analysis. In the 2 periods of treatments, the mean peak plasma concentrations (C(max)) were 59 ng/mL (zolpidem alone) and 35 ng/mL (zolpidem after pretreatment with carbamazepine). The t(max), times taken to reach C(max), were 0.9 hours and 1.0 hour, respectively, and the total areas under the curve (AUC(0-∞)) were 234.9 ng·h/mL and 101.5 ng·h/mL, respectively. The half-life of zolpidem was 2.3 and 1.6 hours, respectively. Carbamazepine interacts with zolpidem in healthy volunteers and lowers its bioavailability by about 57%. The experimental data demonstrate the pharmacokinetic interaction between zolpidem and carbamazepine and suggest that the observed interaction may be clinically significant, but its relevance has to be confirmed. 相似文献
355.
Degrugillier-Chopinet C Bisdorff-Bresson A Laurian C Breviere GM Staumont D Fayoux P Lenica D Gautier C 《Journal des maladies vasculaires》2011,36(6):348-354
Diagnosis of superficial vascular anomalies, previously called "angiomas", is basically clinical. Ultrasound and duplex Doppler imaging is a simple and helpful tool to confirm the clinical diagnosis and/or to suggest further required imaging modalities. The purpose of this work is to demonstrate the usefulness of duplex Doppler and ultrasound for exploring vessel and soft tissue components of vascular anomalies. 相似文献
356.
Vlase L Imre S Muntean D Leucuta SE 《Journal of pharmaceutical and biomedical analysis》2007,44(3):652-657
A new sensitive and selective liquid chromatography coupled with mass spectrometry (LC/MS/MS) method for quantification of loratadine (LOR) and its active metabolite descarboethoxyloratadine (DSL) in human plasma was validated. After addition of the internal standard, metoclopramide, the human plasma samples (0.3 ml) were precipitated using acetonitrile (0.75 ml) and the centrifuged supernatants were partially evaporated under nitrogen at 37 degrees C at approximately 0.3 ml volume. The LOR, DSL and internal standard were separated on a reversed phase column (Zorbax SB-C18, 100 mmx3.0 mm i.d., 3.5 microm) under isocratic conditions using a mobile phase of an 8:92(v/v) mixture of acetonitrile and 0.4% (v/v) formic acid in water. The flow rate was 1 ml/min and the column temperature 45 degrees C. The detection of LOR, DSL and internal standard was in MRM mode using an ion trap mass spectrometer with electrospray positive ionisation. The ion transitions were monitored as follows: 383-->337 for LOR, 311-->(259+294+282) for DSL and 300-->226.8 for internal standard. Calibration curves were generated over the range of 0.52-52.3 ng/ml for both LOR and DSL with values for coefficient of determination greater than 0.994 by using a weighted (1/y) quadratic regression. The lower limits of quantification were established at 0.52 ng/ml LOR and DSL, respectively, with an accuracy and precision less than 20%. Both analytes demonstrated good short-term, long-term, post-preparative and freeze-thaw stability. Besides its simplicity, the sample treatment allows obtaining a very good recovery of both analytes, around 100%. The validated LC/MS/MS method has been applied to a pharmacokinetic study of loratadine tablets on healthy volunteers. 相似文献
357.
Daniel Thomas Malone Dennis Jongejan David Alan Taylor 《Pharmacology, biochemistry, and behavior》2009,93(2):91-96
While Δ9-tetrahydrocannabinol (THC) is the main psychoactive constituent of the cannabis plant, a non-psychoactive constituent is cannabidiol (CBD). CBD has been implicated as a potential treatment of a number of disorders including schizophrenia and epilepsy and has been included with THC in a 1:1 combination for the treatment of conditions such as neuropathic pain. This study investigated the effect of THC and CBD, alone or in combination, on some objective behaviours of rats in the open field. Pairs of rats were injected with CBD or vehicle followed by THC or vehicle and behaviour in the open field was assessed for 10 min. In vehicle pretreated rats THC (1 mg/kg) significantly reduced social interaction between rat pairs. Treatment with CBD had no significant effect alone, but pretreatment with CBD (20 mg/kg) reversed the THC-induced decreases in social interaction. A higher dose of THC (10 mg/kg) produced no significant effect on social interaction. However, the combination of high dose CBD and high dose THC significantly reduced social interaction between rat pairs, as well as producing a significant decrease in locomotor activity. This data suggests that CBD can reverse social withdrawal induced by low dose THC, but the combination of high dose THC and CBD impairs social interaction, possibly by decreasing locomotor activity. 相似文献
358.